BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang B, Xie Z, Li B. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis. Gene 2019;689:76-83. [PMID: 30552981 DOI: 10.1016/j.gene.2018.12.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Echeverría C, Nualart F, Ferrada L, Smith GJ, Godoy AS. Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy. Trends in Endocrinology & Metabolism 2021;32:198-211. [DOI: 10.1016/j.tem.2020.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Lai B, Lai Y, Zhang Y, Zhou M, Sheng L, OuYang G. The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia. Technol Cancer Res Treat 2020;19:1533033819894308. [PMID: 31918632 DOI: 10.1177/1533033819894308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Yamanaka M, Shinya T, Otomi Y, Kubo M, Arai Y, Toba H, Bando Y, Otsuka H, Harada M. Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study. Nucl Med Commun 2020;41:1189-98. [PMID: 32796454 DOI: 10.1097/MNM.0000000000001271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu W, Hu Z, Zhao Q, Zhang X, Zhang H, Wang H, Xue W, Yu L, Duan G. Down-Regulation of Hypoxia-Inducible Factor-1α and Downstream Glucose Transporter Protein-1 Gene by β-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor. Onco Targets Ther 2020;13:11627-35. [PMID: 33223837 DOI: 10.2147/OTT.S275956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kang MK, Lee SY, Choi JE, Baek SA, Do SK, Lee JE, Park J, Yoo SS, Choi S, Shin KM, Jeong JY, Park JY. Prognostic significance of genetic variants in GLUT1 in stage III non-small cell lung cancer treated with radiotherapy. Thorac Cancer 2021;12:874-9. [PMID: 33522072 DOI: 10.1111/1759-7714.13851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kozal K, Jóźwiak P, Krześlak A. Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy. Cancer Control 2021;28:10732748211041243. [PMID: 34554006 DOI: 10.1177/10732748211041243] [Reference Citation Analysis]
7 Guo W, Sun S, Guo L, Song P, Xue X, Zhang H, Zhang G, Li R, Gao Y, Qiu B, Tan F, Xue Q, Gao S, He J. Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics. DNA Cell Biol 2020;39:631-44. [PMID: 32096653 DOI: 10.1089/dna.2019.5291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang Y, Du H, Li Y, Yuan Y, Chen B, Sun S. Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma. Cancer Sci 2020;111:637-46. [PMID: 31677335 DOI: 10.1111/cas.14226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
9 Catalán M, Olmedo I, Faúndez J, Jara JA. Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity. Int J Mol Sci 2020;21:E8684. [PMID: 33217901 DOI: 10.3390/ijms21228684] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang Y, Zheng C, Lu W, Wang D, Cheng Y, Chen Y, Hou K, Qi J, Liu Y, Che X, Hu X. Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer. Front Oncol 2021;11:620154. [PMID: 33763356 DOI: 10.3389/fonc.2021.620154] [Reference Citation Analysis]
11 Huang G, Zhang J, Gong L, Huang Y, Liu D. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. BMC Cancer 2021;21:626. [PMID: 34044809 DOI: 10.1186/s12885-021-08360-z] [Reference Citation Analysis]
12 Xiong Y, Lei J, Zhao J, Lu Q, Feng Y, Qiao T, Xin S, Han Y, Jiang T. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis. BMC Cancer 2020;20:1046. [PMID: 33129284 DOI: 10.1186/s12885-020-07473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Imai H, Kaira K, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Kosaka T, Yajima T, Ohtaki Y, Osaki T, Kogure Y, Tanaka S, Fujita A, Oyama T, Minato K, Asao T, Shirabe K. Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma. J Clin Med 2020;9:E413. [PMID: 32028659 DOI: 10.3390/jcm9020413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Jin X, Liang Y, Liu D, Luo Q, Cai L, Wu J, Jia L, Chen WL. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma. Cell Biol Toxicol 2019;35:471-83. [PMID: 31102011 DOI: 10.1007/s10565-019-09478-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gkika E, Benndorf M, Oerther B, Mohammad F, Beitinger S, Adebahr S, Carles M, Schimek-Jasch T, Zamboglou C, Frye BC, Bamberg F, Waller CF, Werner M, Grosu AL, Nestle U, Kayser G. Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer. Front Oncol 2020;10:1161. [PMID: 32903606 DOI: 10.3389/fonc.2020.01161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Montrose DC, Galluzzi L. Drugging cancer metabolism: Expectations vs. reality. Int Rev Cell Mol Biol 2019;347:1-26. [PMID: 31451211 DOI: 10.1016/bs.ircmb.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
17 Sampedro-Núñez M, Bouthelier A, Serrano-Somavilla A, Martínez-Hernández R, Adrados M, Martín-Pérez E, Muñoz de Nova JL, Cameselle-Teijeiro JM, Blanco-Carrera C, Cabezas-Agricola JM, Díaz JÁ, García-Centeno R, Aragones J, Marazuela M. LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors. Cancers (Basel) 2020;12:E2968. [PMID: 33066332 DOI: 10.3390/cancers12102968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tang JY, Li DY, He L, Qiu XS, Wang EH, Wu GP. HPV 16 E6/E7 Promote the Glucose Uptake of GLUT1 in Lung Cancer Through Downregulation of TXNIP Due to Inhibition of PTEN Phosphorylation. Front Oncol 2020;10:559543. [PMID: 33282728 DOI: 10.3389/fonc.2020.559543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 El Hassouni B, Granchi C, Vallés-martí A, Supadmanaba IGP, Bononi G, Tuccinardi T, Funel N, Jimenez CR, Peters GJ, Giovannetti E, Minutolo F. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies. Seminars in Cancer Biology 2020;60:238-48. [DOI: 10.1016/j.semcancer.2019.08.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
20 Smolle E, Leko P, Stacher-Priehse E, Brcic L, El-Heliebi A, Hofmann L, Quehenberger F, Hrzenjak A, Popper HH, Olschewski H, Leithner K. Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer. Mol Oncol 2020;14:2853-67. [PMID: 32777161 DOI: 10.1002/1878-0261.12780] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
21 Meng F, Zhang L, Ren Y, Ma Q. Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer Biomark 2020;29:475-82. [PMID: 32831194 DOI: 10.3233/CBM-200110] [Reference Citation Analysis]
22 Ancel J, Perotin JM, Dewolf M, Launois C, Mulette P, Nawrocki-Raby B, Dalstein V, Gilles C, Deslée G, Polette M, Dormoy V. Hypoxia in Lung Cancer Management: A Translational Approach. Cancers (Basel) 2021;13:3421. [PMID: 34298636 DOI: 10.3390/cancers13143421] [Reference Citation Analysis]
23 Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules 2020;10:E868. [PMID: 32517099 DOI: 10.3390/biom10060868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Krawczyk MA, Kunc M, Styczewska M, Gabrych A, Karpinsky G, Izycka-Swieszewska E, Bien E. High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor. Diagnostics (Basel) 2021;11:598. [PMID: 33810575 DOI: 10.3390/diagnostics11040598] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Sun R, Ma C, Wang W, Yang S. Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods. PeerJ 2020;8:e8420. [PMID: 32095325 DOI: 10.7717/peerj.8420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]